Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine on Tuesday announced he will “step down in mid-March after leading the organization for five years,” according to a Global Fund press release (1/24). In a message to staff, Kazatchkine said he “concluded that I should not continue as executive director” following a November decision by the Global Fund Board to “appoint a general manager to oversee implementation of the Consolidated Transformation Plan who will report directly to the Board.” The statement continues, “I respect this decision and trust that it was made in the best interests of the Global Fund. … I am committed to an orderly transition, and I will do all that I can to ensure that the Global Fund emerges from it as a stronger organization” (1/24). In a statement, Board Chair Simon Bland said, “I thank Michel for his remarkable contribution and I look forward to working with him to ensure an efficient transition” (1/24).
“As the Global Fund [to Fight AIDS, Tuberculosis and Malaria] turns 10 on January 26, 2012, Nigerian families should join in the celebration of this innovative initiative that has saved the lives of millions here in Nigeria and across the globe,” Bello Bissalla, project manager for private sector and government partnerships at Friends of the Global Fund Africa, writes in Nigeria’s BusinessDay. “Much of the Global Fund’s success could be attributed to its performance-based financing mechanism, which creates room for transparency in the purchase, distribution and administration of drugs for these three diseases,” Bissalla continues, noting the grant review process “ensures that grant recipients show verified evidence of performance before receiving the next tranche of funding, thus ensuring transparency and implementation of the grant according to the plan.”
A funding shortfall led the Global Fund to Fight AIDS, Tuberculosis and Malaria to announce in November that “it won’t make any grants to fund programs for at least two years,” a Deseret News editorial notes and calls on the U.S. to take a leadership position in saving the fund. The editorial states, “Few worldwide initiatives have the success record of the Global Fund …, but those breakthroughs may not have much chance to save many lives,” and notes that the non-profit lobbying group “Results is calling for the Obama administration to assemble an emergency meeting of donor nations this spring to find ways to ensure that the fund and its programs are able to continue and to provide new medicines where they are needed most.”
International HIV/AIDS Alliance Releases Report Examining Potential Effects Of Global Fund Shortfall
The non-governmental organization (NGO) International HIV/AIDS Alliance has released a new report in response to the Global Fund to Fight AIDS, Tuberculosis and Malaria’s announcement in November that “no new grants would be approved until 2014,” VOA News reports. According to the news service, the report, titled “Don’t Stop Now,” “examines the potential effects of the funding shortfall in five countries.”
Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday “urged Ukraine to step up its efforts to fight the HIV/AIDS epidemic,” calling “on the Ukrainian authorities to expand opiate substitution therapy, ensure HIV/AIDS treatment in prison and increase government funding of anti-AIDS programs,” the Associated Press reports. “‘This is the region of the world — the only region of the world — where the AIDS epidemic is still growing,’ Kazatchkine told reporters in Kiev, adding that other countries have managed to stabilize their epidemics,” the news service writes. “The United Nations says Ukraine has Europe’s worst AIDS epidemic, with 1.3 percent of the population above [age] 15 infected with HIV,” according to the AP (1/16).
The January issue of the WHO Bulletin features an editorial on non-communicable diseases and post-conflict countries; a public health round-up; an article on Arab health professionals; a research paper on caesarean section rates in China; and a series of round table articles on the Global Fund and the interaction of public and private interests (January 2011).
This Medecins Sans Frontieres (MSF) special report highlights the top 10 stories of 2011 regarding access to essential medicines, according to MSF. The list includes the findings of the HPTN 052 clinical trial, which “show that providing people with HIV treatment early not only saves their lives but can reduce the risk…
Though Russia is doubling its budget for HIV in 2012 over 2010 levels, “no money will go to such internationally recognized efforts as needle exchanges” and methadone replacement therapy, Reuters reports. “Moscow doesn’t believe these approaches help slow the spread of HIV/AIDS,” and “[s]ome health workers and global HIV authorities are angered and baffled by Russia’s approach, which they say will only aggravate the problem,” the news service writes. The article examines how government spending for HIV will be used, with only three percent of about $600 million expected to go toward prevention programs in 2012, and how non-governmental organizations are coping with cuts in funding from international donor programs (Ferris-Rotman/Koppel, 12/21).
In this post on the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, Kent Campbell, director of the Malaria Control Program at PATH, says “dramatic gains” made in the fight against malaria, and the possibility of ending the disease, are in jeopardy because the “Global Fund to Fight AIDS, Tuberculosis and…
In this post on the Center for Global Development’s (CGD) “Global Health Policy” blog, Denizhan Duran and Amanda Glassman of CGD review the proposed FY12 federal global health appropriation approved recently by Congress. They state that “this year’s budget is a missed opportunity in a period defined by budget pressures: global…